Senti Biosciences to form holding company via tax-free merger; stock to trade as SNTI

Senti Biosciences, Inc.

Holding company reorganization effective April 16, 2026 via merger into Senti Biosciences Holdings.
Each share of common stock automatically converts into one share of holding company common stock with same rights.
No stockholder vote or action required; no gain/loss recognized for U.S. federal income tax purposes.
New holding company will have same directors, officers, assets, and operations as current company.
Stock continues trading on Nasdaq under SNTI with a new CUSIP number.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.